Stock Analysis on Net

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

AbbVie Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Short-term borrowings 4.05 1.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.04 0.04 0.01
Current portion of long-term debt and finance lease obligations 1.43 2.77 5.03 8.76 8.87 6.85 5.34 3.75 3.84 2.08 2.98 6.51 8.32 6.94 8.52 4.47 5.33 7.53 5.62 3.16 3.55 4.12
Accounts payable and accrued liabilities 23.51 22.80 23.63 21.26 20.66 21.04 22.75 21.77 19.97 18.42 18.30 16.63 15.74 15.76 15.49 14.69 14.05 13.69 13.39 12.97 12.89 13.94
Current liabilities 28.99% 26.73% 28.67% 30.02% 29.53% 27.89% 28.09% 25.53% 23.82% 20.51% 21.28% 23.15% 24.08% 22.71% 24.02% 19.17% 19.38% 21.23% 19.04% 16.16% 16.48% 18.06%
Long-term debt and finance lease obligations, excluding current portion 45.89 47.39 44.64 40.79 40.90 42.86 38.75 40.84 41.23 44.07 42.60 42.74 42.60 44.36 43.81 49.74 50.17 49.29 51.51 54.99 54.88 69.39
Deferred income taxes 1.86 1.90 1.91 1.92 1.92 1.83 1.45 1.50 1.57 1.57 1.58 1.40 1.57 1.98 2.05 2.42 2.47 2.50 2.42 3.00 3.20 1.05
Other long-term liabilities 23.36 22.91 22.29 23.03 22.85 22.02 24.00 23.23 23.86 23.97 22.08 21.38 21.49 19.57 19.59 19.55 19.46 17.85 18.34 15.63 15.59 19.63
Long-term liabilities 71.11% 72.19% 68.84% 65.74% 65.66% 66.70% 64.19% 65.57% 66.66% 69.61% 66.27% 65.51% 65.67% 65.90% 65.45% 71.71% 72.10% 69.65% 72.27% 73.62% 73.67% 90.07%
Total liabilities 100.10% 98.93% 97.51% 95.77% 95.19% 94.59% 92.28% 91.10% 90.47% 90.11% 87.55% 88.66% 89.74% 88.61% 89.47% 90.88% 91.49% 90.88% 91.30% 89.78% 90.15% 108.13%
Common stock, $0.01 par value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02
Common stock held in treasury, at cost -6.67 -6.71 -6.07 -5.47 -5.52 -5.26 -4.85 -4.79 -4.82 -4.85 -3.31 -3.25 -3.21 -3.20 -2.14 -2.03 -2.04 -2.00 -1.50 -1.32 -1.31 -27.53
Additional paid-in-capital 16.03 16.02 15.78 14.75 14.71 13.87 14.98 14.70 14.66 14.58 13.86 13.48 13.20 13.08 12.49 12.16 12.12 11.77 11.55 11.46 11.34 16.89
Retained earnings (accumulated deficit) -8.39 -7.00 -5.84 -3.46 -2.65 -1.60 -0.74 0.68 1.32 1.78 3.45 3.50 2.46 3.56 2.13 1.07 0.50 1.52 0.70 2.23 2.09 6.55
Accumulated other comprehensive loss -1.12 -1.28 -1.42 -1.63 -1.77 -1.65 -1.71 -1.73 -1.66 -1.66 -1.58 -2.44 -2.23 -2.08 -1.98 -2.12 -2.10 -2.19 -2.07 -2.18 -2.30 -4.05
Stockholders’ equity (deficit) -0.13% 1.04% 2.46% 4.21% 4.78% 5.38% 7.69% 8.88% 9.50% 9.87% 12.43% 11.32% 10.23% 11.37% 10.52% 9.10% 8.49% 9.11% 8.68% 10.21% 9.84% -8.13%
Noncontrolling interest 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.02 0.00
Total equity (deficit) -0.10% 1.07% 2.49% 4.23% 4.81% 5.41% 7.72% 8.90% 9.53% 9.89% 12.45% 11.34% 10.26% 11.39% 10.53% 9.12% 8.51% 9.12% 8.70% 10.22% 9.85% -8.13%
Total liabilities and equity (deficit) 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Short-term borrowings
The proportion of short-term borrowings to total liabilities and equity remained minimal from 2020 through most of 2024, generally close to zero. However, in the last two recorded quarters, it increased noticeably to 1.17% and then to 4.05%, indicating a recent shift toward greater reliance on short-term debt.
Current portion of long-term debt and finance lease obligations
This category showed volatility across the reported periods. It ranged from approximately 1.43% to a peak of 8.87%. Notably, there was an increase during late 2024, followed by a decline in mid-2025, suggesting variable short-term debt repayment schedules or refinancing activities.
Accounts payable and accrued liabilities
There was a consistent upward trend in accounts payable and accrued liabilities as a percentage of total liabilities and equity. Starting near 14% in early 2020, the ratio increased steadily, reaching around 23.5% by mid-2025. This rise suggests growing operational liabilities or extended payment terms to suppliers.
Current liabilities
Current liabilities showed an overall upward movement from roughly 18% in early 2020 to a peak of over 30% in late 2024, followed by a slight decrease towards mid-2025. This indicates an increasing share of short-term financial obligations within the capital structure, implying higher near-term liquidity demands.
Long-term debt and finance lease obligations, excluding current portion
This component showed a declining trend initially, falling from nearly 70% in early 2020 to below 39% in late 2021, followed by fluctuations with a moderate upward bias reaching close to 47% in early 2025 before slight decline. The fluctuations signal active long-term debt management, possibly through refinancing or repayments.
Deferred income taxes
The ratio of deferred income taxes to total liabilities and equity remained relatively stable, generally hovering around 1.5% to 3.2%. There is no significant upward or downward trend, indicating a consistent tax-related liability proportion.
Other long-term liabilities
Other long-term liabilities fluctuated moderately within a 15.5% to 24% range but generally showed a slight increasing tendency over time, suggesting a gradual rise in miscellaneous long-term obligations.
Long-term liabilities
Long-term liabilities as a whole demonstrated an overall declining trend from about 90% in early 2020 to a low near 64% in 2021, but gradually climbing back towards 72% by mid-2025. This reflects changes in the composition and volume of long-term debt and other liabilities over the periods.
Total liabilities
Total liabilities relative to total liabilities and equity declined from 108% in early 2020 to a low near 87.5% by late 2022, then progressively increased again approaching 100% by mid-2025. The initial decline and subsequent rise indicate shifts in financial leverage and equity levels.
Common stock, $0.01 par value
The proportion of common stock remained constant and negligible throughout the periods, consistently at about 0.01% to 0.02% of total liabilities and equity, reflecting no significant issuance or repurchase affecting this item.
Common stock held in treasury, at cost
The treasury stock showed a marked increase in negative percentage terms from nearly -27.5% in early 2020, stabilizing around -1.3% early on, then progressively growing in absolute negative value to approximately -6.7% by mid-2025. This trend indicates ongoing repurchase activity increasing the treasury stock balance.
Additional paid-in capital
Additional paid-in capital exhibited a general increasing trend from roughly 11% in 2020 to around 16% by mid-2025, suggesting continued capital injections or stock issuance above par value over time.
Retained earnings (accumulated deficit)
Retained earnings showed considerable fluctuation: initially positive, increasing slightly up to early 2022, but then turned negative starting late 2023, declining progressively to about -8.4% by mid-2025. This signals accumulated losses or dividends exceeding net income, reducing equity base.
Accumulated other comprehensive loss
This item remained negative and fairly stable over time, fluctuating moderately between about -1.1% and -4%, indicating persistent unrealized losses or other comprehensive expense items impacting equity.
Stockholders’ equity (deficit)
Stockholders’ equity as a percentage of total liabilities and equity showed an improving trend from a deficit of -8.1% in early 2020 to a positive peak near 12.4% in late 2022. However, equity contracted thereafter, turning barely positive in early 2025 and slightly negative by mid-2025. This reflects variations in retained earnings, treasury stock, and other equity components impacting net equity position.
Noncontrolling interest
Noncontrolling interest remained minimal and stable, about 0.02% to 0.03% of total liabilities and equity, indicating a negligible but consistent minority interest in consolidated entities.
Total equity (deficit)
Total equity followed the same pattern as stockholders’ equity, improving from negative territory in 2020 to above 12% by end-2022, then decreasing gradually to near zero or slight deficit levels by mid-2025, reflecting the overall equity position’s sensitivity to underlying components.
Total liabilities and equity (deficit)
By definition, this total remains constant at 100% across all periods, serving as the base reference for all relative ratio calculations.